is jardiance a glp-1 Eli Lilly, Boehringer's flops heart failure trial, falling behind AZ's Farxiga GLP-1 Agonists - What is

Contrarily, there was a consistent recovery achieved with the BPC 157 therapy, given at once, soon after injury (i.e., at 10 min post-injury), or much later (i.e., therapy at fourth post-injury day) [28,29]

10.1016/j.phrs.2018.03.020 76 IzzoC.AnnunziataM.MelaraG.SciorioR.DallioM.MasaroneM.et al (2021)

10.1016/j.bmc.2018.01.006 44 DerosaG.MaffioliP.FerrariI.MereuR.RagonesiP

where F = phenylalanine, L = leucine, and X = any amino acid residue a Polyglutamine repeat [59] (AR-B only) Transactivation unit 1 (TAU-1) between residues 101 and 370 required for full ligand-activated transcriptional activity [60] Transactivation unit 5 (TAU-5) between residues 360485 is responsible for the constitutive activity (activity without bound ligand) [60] Despite being highly disordered, the NTD domain adopts a 3D conformation in which two dynamically compact regions form, an N-terminal region (NR) and a C-terminal region (CR), each having distinct topological dynamics and function